Holding above $426.67 opens the door to $449–$453, which could cap upside into October.
1 extracted signal · 1 resolved · 0 still active
Wicked StocksIndependent analyst profile- Source published
- 18 Sept 2025, 16:13 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on TSLA, highlighting a buy signal above 360.76. The analyst suggests that closing above this level sets a 523.03 target within 5 to 8 months, but potentially sooner. The current analysis closed just below 426.11-426.67, but notes a new high settlement price, allowing for a gap above 426.67. A potential target of 449.08 within the day is discussed depending on volatility. If it closes above 426.67 on the day of analysis or Friday (the next day), then it could test 449.08 and then the range begins up to 453.46. Breaking 410.04 intraday, there could be a further fall to 396.03 intraday. If there is any week closing above 453.46 there should be a 523.03 target withing weeks. If 449.08 to 453.46 range is tested, TSLA could fall into a zone of support and 360.76 is the beginning of that range down to 358.30. Finally, if it is over 523.03 remains a 5 to 8 month objective.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Wicked Stocks
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
